HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Shi-Yue Li Selected Research

4-toluenesulfonamide

4/2018Effects of para-toluenesulfonamide intratumoral injection on pulmonary adenoid cystic carcinoma complicating with severe central airway obstruction: a 5-year follow-up study.
1/2016Effects of para-toluenesulfonamide intratumoral injection on non-small cell lung carcinoma with severe central airway obstruction: A multi-center, non-randomized, single-arm, open-label trial.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Shi-Yue Li Research Topics

Disease

6Neoplasms (Cancer)
10/2022 - 01/2016
3Lung Neoplasms (Lung Cancer)
01/2021 - 01/2016
3COVID-19
01/2021 - 01/2020
2Asthma (Bronchial Asthma)
01/2022 - 06/2007
2Airway Remodeling
01/2022 - 06/2007
2Pathologic Constriction (Stenosis)
05/2021 - 01/2021
2Fistula
05/2021 - 01/2019
2Tracheal Stenosis
01/2021 - 01/2019
2Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
01/2021 - 01/2016
2Tuberculosis (Tuberculoses)
01/2021 - 11/2009
2Dyspnea (Shortness of Breath)
04/2018 - 01/2016
2Airway Obstruction (Choking)
04/2018 - 01/2016
2Pulmonary Alveolar Proteinosis
02/2017 - 01/2015
1Lymphopenia (Lymphocytopenia)
01/2021
1HIV Infections (HIV Infection)
01/2019
1Pneumothorax
01/2019
1Adenoid Cystic Carcinoma (Cylindroma)
04/2018
1Flushing
07/2017
1Respiratory Insufficiency (Respiratory Failure)
01/2015
1Respiratory Tract Diseases (Respiratory Tract Disease)
12/2014
1Adenocarcinoma of Lung
12/2014
1Pulmonary Tuberculosis
11/2009
1Respiratory Hypersensitivity
06/2007

Drug/Important Bio-Agent (IBA)

3SiliconesIBA
05/2021 - 01/2019
2Oxygen (Dioxygen)IBA
01/2019 - 01/2015
24-toluenesulfonamideIBA
04/2018 - 01/2016
14- ((1,4,8,11- tetraazacyclotetradec- 1- yl)methyl)benzoic acidIBA
10/2022
1Bronchodilator Agents (Bronchodilators)IBA
01/2022
1SiliconIBA
05/2021
1MetalsIBA
05/2021
1benzoyltyrosine 4-nitroanilideIBA
01/2021
1CrizotinibIBA
01/2021
1Anaplastic Lymphoma KinaseIBA
01/2021
1GemcitabineFDA Link
01/2021
1Cisplatin (Platino)FDA LinkGeneric
01/2021
1Granulocyte Colony-Stimulating Factor (G-CSF)IBA
01/2021
1Immunoglobulin A (IgA)IBA
01/2020
1Serum Amyloid A Protein (Serum Amyloid A)IBA
01/2020
1HydrogenIBA
01/2019
1ThrombinFDA Link
01/2019
1Indicators and Reagents (Reagents)IBA
07/2017
1Contrast MediaIBA
07/2017
1Biomarkers (Surrogate Marker)IBA
02/2017
1Pemetrexed (MTA)FDA Link
12/2014
1ErbB Receptors (EGF Receptor)IBA
12/2014
1Bevacizumab (Avastin)FDA Link
12/2014
1Proteins (Proteins, Gene)FDA Link
11/2009
1platelet protein P47 (pleckstrin)IBA
11/2009
1Interleukin-4 (Interleukin 4)IBA
06/2007
1AllergensIBA
06/2007
1Interleukin-13IBA
06/2007
1Budesonide (Pulmicort)FDA LinkGeneric
06/2007
1STAT6 Transcription FactorIBA
06/2007
1Protein-Tyrosine Kinases (Tyrosine Kinase)IBA
06/2007
1Hydroxyproline (4 Hydroxyproline)IBA
06/2007
1OvalbuminIBA
06/2007

Therapy/Procedure

5Therapeutics
01/2021 - 12/2014
3Stents
05/2021 - 01/2021
3Drug Therapy (Chemotherapy)
01/2021 - 12/2014
1Palliative Care (Palliative Therapy)
05/2021
1Radiofrequency Ablation
01/2021
1Length of Stay
01/2019
1Highly Active Antiretroviral Therapy (HAART)
01/2019
1Aftercare (After-Treatment)
04/2018
1One-Lung Ventilation
01/2015
1Artificial Respiration (Mechanical Ventilation)
01/2015
1Intranasal Administration
06/2007